The VWM Consortium paper is Neurology Genetics’ #2 most read paper of 2022!

In an end-of-the-year countdown on Facebook, the scientific journal ‘Neurology: Genetics’ stated that their #2 most read paper of 2022 is the VWM Consortium paper on therapy trial design.

The VWM Consortium is thankful that this paper has reached so many readers, and will continue their best efforts in 2023 to work towards optimal trial design for VWM patients. Happy 2023!